Big Data Supporting Public Health Hearing Policies

Overview

Hearing Loss (HL) affects over 5% of the world's population (WHO 2014) and is the 5th leading cause of Years Lived with Disability. HL is currently managed with Hearing Aids (HAs), i.e. programmable sound amplification devices that are worn by the hearing impaired subjects to address their hearing difficulties. HA use however is often problematic, costly and with poor overall benefits. The holistic management of HL requires appropriate public health policies for HL prevention, early diagnosis, long-term treatment and rehabilitation; detection and prevention of cognitive decline; and socioeconomic inclusion of HL patients. Currently the evidential basis for forming such policies is limited. The EVOTION project proposes to address this by collecting and analysing a big set of heterogeneous data, including HA usage, audiological, physiological, cognitive, clinical and medication, personal, behavioural, life style, occupational and environmental data. This will be done by: i. accessing big datasets of existing HA user data from the EVOTION clinical partners (UCL/UCLH and GST in the UK; OTICON in Denmark) ii. collection of prospective HA user data who will be recruited to the prospective EVOTION study and who will undergo some additional assessments iii. collection of real time dynamic data of the human participant HA users who will be given a smart phone with different apps (auditory tests; auditory training), sensors (recording of heart rate, blood pressure, respiratory rate etc.) and smart HAs (recording environmental factors such as noise levels, type of noise etc.) so that real life contextual factors that affect HA usage and outcome can be identified. These data will be analysed with big data analysis/data mining techniques in order to identify relationships between these in order to use this information to derive and support public health decisions.

Full Title of Study: “EVidenced Based Management of Hearing Impairments: Public Health pΟlicy Making Based on Fusing Big Data Analytics and simulaTION”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Non-Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Other
    • Masking: None (Open Label)
  • Study Primary Completion Date: November 30, 2018

Interventions

  • Device: Hearing aid
    • Smart hearing aid to allow collection of real time hearing aid usage data
  • Device: Mobile phone
    • Mobile phone linked with the hearing aids to allow users to change the device settings and perform additional listening tests
  • Device: Sensor
    • Wearable biosensor for the collection of physiological data

Arms, Groups and Cohorts

  • Experimental: Hearing aid + mobile phone
  • Experimental: Hearing aid + mobile phone + biosensor

Clinical Trial Outcome Measures

Primary Measures

  • Change in “Glasgow Hearing Aid Benefit Profile” at 8 weeks
    • Time Frame: Baseline (i.e. before the patient receives a hearing-aid) and at 8 weeks after receiving a hearing-aid

Participating in This Clinical Trial

Inclusion Criteria

  • Age >18 years – Basic understanding of oral and written English – Unilateral and/or bilateral mild to severe sensorineural hearing loss – Willing to use smart hearing aids for at least 2 hours daily on average – Willing/capable to use a mobile phone Exclusion Criteria:

  • Dementia (MoCA<22 ) – Not agreeing or able to attend for f/u appointments – Not agreeing or able to use HA >2 hours daily (average) – Not sufficient vision to use smartphone ap

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • University College, London
  • Provider of Information About this Clinical Study
    • Sponsor

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.